Which of the following statements regarding ipratropium bromide are true? 1. It is a first-line choice of bronchodilator for chronic obstructive pulmonary disease (COPD). 2. It can be combined with a agonist for maintenance bronchodilation in COPD.
3. It is added to a agonist in severe asthma episodes that do not respond to a agonist alone.
4. It is a leukotriene modifier used to treat step 3 asthma.
a. 1 and 4 only
b. 2 and 4 only
c. 1, 2, and 4 only
d. 1, 2, and 3 only
Q. 2 Results of a patient's pulmonary function test (PFT) show that the peak flow rate increased the most when she inhaled an aerosolized sympathomimetic agent and an aerosolized parasympatholytic agent.
You would recommend that she be given which of the following?
a. Ventolin MDI
b. Serevent Diskus DPI
c. Combivent Respimat
d. Foradil DPI
Q. 3 Which of the following is a once-a-day anticholinergic?
a. Atropine
b. Ipratropium bromide
c. Glycopyrrolate
d. Umeclidinium bromide
Q. 4 Tiotropium bromide exhibits receptor subtype selectivity for which of the following receptor types?
a. M1 only
b. M2 only
c. M1, M2, and M3
d. M1 and M3
Q. 5 Cardiac effects of aerosolized ipratropium bromide include which of the following?
a. Increased heart rate
b. Increased blood pressure
c. Increased heart muscle contractility
d. Little or no effect
Q. 6 Possible side effects of aerosolized Atrovent include which of the following? 1. Flulike symptoms 2. Pharyngitis 3. Bradycardia 4. Dry mouth 5. Dyspnea
a. 1, 2, and 3 only
b. 1, 2, and 4 only
c. 1, 2, 4, and 5 only
d. 1, 2, 3, 4, and 5
Q. 7 Drugs that competitively block the action of acetylcholine at parasympathetic postganglionic effector cell receptors are called
a. muscarinic agents.
b. adrenergic agents.
c. antimuscarinic agents.
d. cholinergic agents.
Quick Reply
